As one of the least treatable subtypes of stroke, the incidence and all-age mortality of spontaneous intracerebral hemorrhage (ICH) increased over the last decades in China.
of medical decisions including early care limitations, PCE, or do-notresuscitate order. Incorrect assessment of long-term outcome might lead to biased clinical judgment of ICH patients. Even adverse consequences on clinical outcome might be caused if the decisions based on prognostic model that withhold beneficial treatments. 15 Thus, it is essential to predict the prognosis for patients with ICH, especially for neurologists to make high-quality decision or to inform patients' family members choosing appropriate therapy. 16 To evaluate the long-term prognosis of ICH and improve risk stratification, the maximally treated intracerebral hemorrhage (max-ICH) score was developed recently from a cohort without early care limitations. 7 The max-ICH score had a superior predictive validity comparing to previous long-term prognosis scores in ICH patients in total ICH cohort of the derivation dataset. It has not been validated in Asian patients with ICH.
In this study, we aimed to assess the performance of the max-ICH score in Chinese patients from the China National Stroke Registry (CNSR) 17 cohort and compare its performance with other 6 recognized scores, including ICH functional outcome score (ICH-FOS), Essen-ICH score, modified intracerebral hemorrhage (MICH) score, intracerebral hemorrhage grading scale (ICH-GS), and functional outcome (FUNC) score.
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2 | ME THODS
| Data source and subjects
Data of this study were derived from the CNSR. Detailed description of rationale and design as well as baseline characteristics was published previously. 17 The CNSR recruited 21 902 patients who were hospital- Organization criteria. 17 Major exclusion criteria were secondary ICH (caused by trauma, underlying tumor, or brain structural abnormalities with concrete evidence), any of the components of max-ICH score unavailable or incomplete follow-up data ( Figure 1 ).
| Max-intracerebral hemorrhage score and other six predictive scores
The max-ICH score was obtained by adding up items for NIHSS score (Table S1 ). The highest max-ICH total score was 9 points as none of the ICH patients were with 2 distinct location of hemorrhage.
The ICH-FOS score was obtained by adding up items for age . 10 The volume of hematoma was assessed using the ABC/2 method. 18 The ICH score is one of the most widely accepted scores. [19] [20] [21] It was obtained by adding up items for: GCS (15-13 = 0; 12-5 = 1;
4-3 = 2), hematoma volume (<30 cm 3 = 0; ≥30 cm 3 = 1), presence of F I G U R E 1 Flowchart of patient selection for the study. IS, indicates ischemic stroke; TIA, transient ischemic attack; ICH, intracerebral hemorrhage intraventricular hemorrhage (no = 0; yes = 1), infra-tentorial origin (no = 0; yes = 1), age (<80 = 0; ≥80 = 1).
9
The Essen-ICH score was calculated by adding up points as- (≥9 = 2; ≤8 = 0), pre-ICH cognitive impairment (no = 1; yes = 0).
13
The lobar ICH was defined as ICH originating from brain cortex or cortical-subcortical junction. Nonlobar ICH was defined as ICH originating from deep, cerebellar, and brainstem origin. 22, 23 Deep ICH comprised ICH that exclusively involving basal ganglia, thalamus, internal capsule, and deep periventricular white matter. 22 
| Clinical outcomes
The primary outcome of this study was unfavorable long-term (12-month) functional outcome after symptoms onset, which was defined as the mRS of 4-6 based on the original article of derivation study. 
| Statistical analysis
Categorical variables were presented as percentages; continuous variables were presented as mean and SD or median (IQR) depending on whether the variable is normally distributed or skewed.
We used Shapiro-Wilk test to examine the normality of continuous variables including the area under the receiver-operator curve (AUC) of each included predicting models. Odds ratios with 95%
confidence intervals (CIs) were calculated with multivariable logistic regression.
The discriminatory power of the max-ICH score was assessed by AUC and 95% CI. An AUC statistic of 1.0 indicates perfect prediction, and of 0.5 indicates no better than random prediction.
Calibration was assessed using Pearson correlation coefficient and Hosmer-Lemeshow goodness-of-fit test. Mann-Whitney and Delong method were used for comparisons of pairwise AUCs among max-ICH score and 6 other scores. 24 Level of significance was determined as P < 0.05, 2-sided. All statistical analyses were performed using SAS version 9.4 software (SAS Institute Inc., Cary, NC, USA).
| RE SULTS

| Patient characteristics
Our study included 2851 ICH patients who met the inclusion criteria ( Figure 1 ). The mean age of included patients was 61.9 years, and 38.2% of them were female. The baseline characteristics, medical history and clinical characteristics of this study population, and the population which were used to develop the max-ICH score were listed in Table 1 . and FUNC score (Figure 2A ). Pairwise comparison of using nonparametric tests between max-ICH and the other six scores yielded differing ROC for four scores (max-ICH, ICH, Essen-ICH, and ICH-GS score).
Differences in ROCs were observed between max-ICH and three other included scores (ICH-FOS, Essen-ICH, and FUNC) (Table 2).
For prediction of 12-month death, Essen-ICH score had the largest and FUNC score the smallest ROC ( Figure 2B ). Meanwhile, max-ICH, ICH score, ICH-FOS, and ICH-GS performed well with ROCs of 0.81, 0.81, 0.83, and 0.82, respectively ( Table 2 ).
The max-ICH score also performed well in the calibration analysis ( Figure S1 ). The Hosmer-Lemeshow test correlation coefficient between observed and predicted probability of unfavorable or fa- The high correlation between the observed and max-ICH score predicted probability of favorable outcome (Wald chi-square 13.0)
indicates the usability of the max-ICH grading scale for identifying patients with potential probability to reach good prognosis.
| D ISCUSS I ON
Compared with 6 other recognized scales, we found that max-ICH score had a reliable or even superior performance in predicting unfavorable long-term functional outcome of ICH and stratifying patients with the probabilities of favorable outcome.
The max-ICH score was developed in a maximally treated ICH patient cohort in a single center in Germany to minimize the confounding effects of early care limitations. Our study performed the external validation of the max-ICH score in a nation-wide multicenter cohort which avoid the specificity of single-center characteristics. However, the max-ICH score was not superior to the ICH-FOS score, which was developed from the CNSR cohort with good result in internal validation. Unlike the requirement of admission glucose of the ICH-FOS score, 10 or the knowledge of cognitive status before ICH when calculating the FUNC score, 13 as soon as getting the age of ICH patient, the result of physical and neurological examination and cranial CT scan that revealing the location and volume of the hematoma, the max-ICH score could be obtained timely.
The items of the max-ICH score were all established risk factors of unfavorable long-term functional outcome. 25 Correlations between the items were also reported to be associated with outcome of ICH. Incidence of ICH with different etiologies and mechanisms was varied by age. 26 Cerebral amyloid angiopathy (CAA) attributed a large proportion of intracerebral hemorrhage in the elder population. Age-dependent incidence of CAA was evidently increased from 13.8% of 60 and 69 years group to 44.8% of 80 years and older group. 27 Baseline hematoma volume and hematoma expansion were associated with neurological deterioration after ICH and predicted unfavorable short-term outcome. 28 The correlation between age and hematoma volume was also discovered in ICH patients as hematoma volume tended to increase in lobar ICH patients older than 70 years. 29 Extension of hematoma into ventricles and higher severity (evaluated by NIHSS score) were significantly associated with unfavorable outcome after spontaneous ICH. 5, [30] [31] [32] The max-ICH score is an integral tool including the quantifiable risk factors of unfavorable outcome.
We recognized superior prognostic utility of ICH-FOS score and Essen-ICH score compared with max-ICH score. Differences between the max-ICH score and ICH-FOS score were categorical method of ICH location and inclusion of admission serum glucose. According to the analysis based on INTERACT-2, worst short-term (90-day) outcome was seen in patients with ICH in posterior limb of internal capsule or thalamus. 31 Both locations were included in the same category in the 2 scores. However, impaired glucose regulation independently associated with poor functional outcome of ICH patients. [33] [34] [35] The inclusion of admission serum glucose might be the critical component which leads to a higher discrimination power of predicting the unfavorable outcome of ICH patients using ICH-FOS score than the max-ICH score. The level of consciousness was reported to be one of the most significant factors of poor outcome of ICH patients. 36 The superior performance of Essen-ICH score in recognizing unfavorable long-term outcome of ICH patients might due to highlighting the importance of consciousness level.
There were certain strengths of this study. First, the CNSR was a prospective cohort of acute-phase stroke, and multicenter registry, which allowed the validation as unbiased by single-center character- 37, 38 Second, the follow-up by phone interview might introduce misjudgment into the functional outcome evaluation. Evidence from previous studies indicated that structured telephone assessment of the modified Rankin Scale is reliable and comparable with face-to-face interview with good agreement. 39, 40 The phone interviewers were all personnel at Beijing
Tiantan Hospital who received centralized training using identical questionnaire which would help reducing bias causing by potential inconsistency of the results to a certain extent. Interobserver and intraobserver consistency pretests among phone interviewers might be solutions to the concern of inconsistency. Third, the max-ICH score did not include medical history or prestroke dependence status, which might lead to confounding effects of comorbidities.
It is important to obtain detailed medical history for supplement to avoid underestimation of unfavorable outcome because of compromised organ function due to prestroke chronic diseases. 
| CON CLUS IONS
The max-ICH score is a useful tool to evaluate the long-term functional outcome and to identify patients in whom full medical support is potentially benefit in ICH patients. This could be useful for improving risk stratification of ICH patients in research and clinical practice.
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